602 related articles for article (PubMed ID: 29370410)
21. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
[TBL] [Abstract][Full Text] [Related]
22. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
[TBL] [Abstract][Full Text] [Related]
23. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
24. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
25. The Salivary Microbiome in Polycystic Ovary Syndrome (PCOS) and Its Association with Disease-Related Parameters: A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Pieber TR; Gorkiewicz G; Obermayer-Pietsch B
Front Microbiol; 2016; 7():1270. PubMed ID: 27610099
[TBL] [Abstract][Full Text] [Related]
26. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
27. The interplay between PCOS pathology and diet on gut microbiota in a mouse model.
Rodriguez Paris V; Wong XYD; Solon-Biet SM; Edwards MC; Aflatounian A; Gilchrist RB; Simpson SJ; Handelsman DJ; Kaakoush NO; Walters KA
Gut Microbes; 2022; 14(1):2085961. PubMed ID: 35787106
[TBL] [Abstract][Full Text] [Related]
28. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
29. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
30. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
31. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome.
Eyupoglu ND; Ergunay K; Acikgoz A; Akyon Y; Yilmaz E; Yildiz BO
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32860695
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
33. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
Song DK; Oh JY; Lee H; Sung YA
Korean J Intern Med; 2017 Jul; 32(4):690-698. PubMed ID: 27899014
[TBL] [Abstract][Full Text] [Related]
34. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
[TBL] [Abstract][Full Text] [Related]
35. Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole.
Li Y; Zhu Y; Li D; Liu W; Zhang Y; Liu W; Zhang C; Tao T
Front Endocrinol (Lausanne); 2023; 14():1265152. PubMed ID: 37929036
[TBL] [Abstract][Full Text] [Related]
36. Changes in Vaginal Microbiome Diversity in Women With Polycystic Ovary Syndrome.
Lu C; Wang H; Yang J; Zhang X; Chen Y; Feng R; Qian Y
Front Cell Infect Microbiol; 2021; 11():755741. PubMed ID: 34804995
[TBL] [Abstract][Full Text] [Related]
37. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
38. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
[TBL] [Abstract][Full Text] [Related]
39. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
He F; Li Y
J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
[TBL] [Abstract][Full Text] [Related]
40.
Hassan S; Kaakinen MA; Draisma H; Zudina L; Ganie MA; Rashid A; Balkhiyarova Z; Kiran GS; Vogazianos P; Shammas C; Selvin J; Antoniades A; Demirkan A; Prokopenko I
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
